Maxwell D. Janosky, MD Castle Connolly Top Doctor

Maxwell D. Janosky, MD

  • Hematology
  • Oncology
Locations & Appointments

Languages Spoken

  • Russian
  • Spanish
Show Menu

Primary Areas of Practice

  • Hematology
  • Oncology

Other Areas of Practice

  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Amyloidosis
  • Anemia
  • Bladder Cancer
  • Bleeding Disorders
  • Bloodless Medicine
  • Bone Marrow Failure
  • Breast Cancer
  • Cancer Prevention
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Clotting Disorders
  • Colorectal Cancer
  • Esophageal Cancer
  • Essential Thrombocythemia
  • Factor Deficiency
  • Gallbladder Cancer
  • Hemoglobinopathy
  • Integrative Medicine
  • Kidney Cancer
  • Leukemia
  • Leukopenia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin
  • Macroglobulinemia
  • Mesothelioma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Myeloma
  • Neutropenia
  • Palliative Care
  • Pancreatic Cancer
  • Polycythemia
  • Polycythemia Vera
  • Sickle Cell Disease
  • Stomach Cancer
  • Testicular Cancer
  • Thalassemia
  • Thrombocytopenia
  • Waldenstrom Macroglobulinemia
  • White Blood Cell Disorders

Procedures

  • Cancer Pain Management
  • Chemotherapy
  • Immunotherapy
  • Infusion Therapy
  • Intrathecal Therapy
  • Plasmapheresis and Exchange
  • Targeted Therapy

Conditions Treated

  • Brain Cancer
  • Cervical Cancer
  • Head and Neck Cancers
  • Laryngeal Cancer
  • Melanoma
  • Oral Cancer
  • Ovarian Cancer
  • Sarcoma
  • Skin Cancer
  • Throat Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Locations

  • Hematology Oncology Physicians of Englewood, PA

    A

    350 Engle Street 5th Floor, Berrie Center Englewood, NJ 07631

    Main: 201-568-5250
    Fax: 201-568-5358

    Monday
    8:30 AM
    5:00 PM
    Tuesday
    1:00 PM
    5:00 PM
    Wednesday
    8:30 AM
    5:00 PM
    Thursday
    8:30 AM
    5:00 PM
    Friday
    8:30 AM
    5:00 PM
  • Hematology Oncology Physicians of Englewood, PA

    A

    350 Engle Street 6th Floor, Berrie Center Englewood, NJ 07631

    Main: 201-568-5250
    Fax: 201-568-5358

    Tuesday
    9:00 AM
    12:00 PM

Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)

Aetna

  • Aetna HMO
  • Aetna Medicare Managed Care
  • Aetna POS
  • Aetna PPO
  • Medsolutions
  • Meritan Health

Amerigroup

  • Amerigroup Medicaid
  • Amerivantage

AmeriHealth

  • AmeriHealth Administrator
  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)

APWU

  • APWU Health Plan

Cigna

  • Cigna HMO
  • Cigna PPO
  • Cigna Supplemental
  • Great-West Healthcare (GWH)
  • Health Partners

Clover Health

  • Clover Health

Consumer Health Network (CHN)

  • CHN PPO

CoreSource

  • CoreSource

Coventry

  • CCN

EmblemHealth

  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth GHI CBP
  • EmblemHealth GHI PPO
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Access Network
  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS HMO
  • Empire BCBS POS
  • Empire BCBS PPO
  • Pathway EPO
  • Pathway HMO
  • Prism
  • Silver
  • Total Blue

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

First Health

  • First Health

Galaxy Health Network PPO

  • Galaxy Health Network PPO

GEHA

  • GEHA Health Plan

Horizon BCBS

  • Federal Employee Program
  • Horizon BCBS EPO
  • Horizon BCBS HMO
  • Horizon BCBS Medicare Managed Care
  • Horizon BCBS PPO
  • NJ Carpenters Fund
  • OMNIA Tier 1
  • Traditional

Horizon NJ Health

  • Horizon NJ Health Medicaid

MagnaCare

  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)

Medicaid

  • Medicaid NJ

Medicare

  • Medicare NJ

MultiPlan/PHCS

  • Beech Street
  • MultiPlan Humana
  • MultiPlan Worker's Comp
  • PHCS
  • Pomco

MVP Health Care

  • MVP Health Care PPO

NALC

  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits

Oxford

  • Freedom
  • Garden State Network
  • Liberty
  • Metro
  • Oxford Medicare

QualCare

  • Choice Care
  • HIP HMO
  • HIP PPO
  • HIP PRIME HMO
  • HIP PRIME PPO
  • Oscar
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

TRICARE North Region

  • CHAMPVA
  • DVA

UMR

  • UMR

United Healthcare Community and State

  • Dual Complete
  • United Healthcare Community and State Medicaid (NJ Family Care)
  • United Healthcare Community and State Medicare

UnitedHealthcare

  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • Medica
  • River Valley
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare StudentResources

Wellcare

  • Wellcare Medicaid Managed Care
  • Wellcare Medicare Managed Care

About Maxwell Janosky

Dr. Janosky is board certified in internal medicine, hematology, and oncology. A member of the Englewood Health Physician Network, he specializes in blood disorders, blood cancer, brain cancer, head and neck cancer, endocrine cancer, dermatological cancer, and gynecological cancer. He has also practiced as a leukemia and lymphoma hospitalist. Dr. Janosky has particular interest in biologic agents, cancer prevention, chemotherapy, hereditary cancer predisposition, immunologic approaches, and pain management and palliative care. After receiving his MD from Loma Linda University, he did an internal medicine residency at the University of California, San Francisco, and a hematology/oncology fellowship at New York University. He participates in clinical trials, as well as an ongoing basic science project on matrix metalloproteinase inhibition for the prevention of breast cancer metastasis.

Honors & Awards

2020, 2019: Bergen Magazine Top Doctors

2020, 2019: Castle Connolly Top Doctor New York Metro Area

2020, 2019: Castle Connolly Regional Top Doctor

2019: Jersey's Best Magazine Top Doctor

2014: Franco Muggia Clinical Trials Award, New York University

Professional Memberships

American Society of Hematology

American Society of Clinical Oncology

Committees and Leadership Positions

Medicine Professional Practice Committee, Department of Hematology and Oncology

VTE Committee

2009-2010: Mentor, Residency Diversity Committee Mentorship Program, University of California, San Francisco

Global Health and Community Health Activities

2017: A Community Conversation on Prostate Cancer Education

Education & Degrees

MD: Loma Linda University School of Medicine

Residency

UCSF Medical Center

Fellowship

New York University Medical Center, Hematology/Oncology

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Other Certifications

  • Optune®-Certified

Publications

Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, Schatz-Siemers N, Zeng J, Adams S, Mignatti P. Inhibition of Breast Cancer Metastases by Presurgical Treatment with an Oral Matrix Mettaloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Molecular Cancer Therapeutics. July 27 2016. 15 (10): 2370-2377.

Janosky M, Bian J, Dhage S, Levine J, Silverman J, Jors K, Moy L, Cangiarella J, Muggia F, Adams S. Primary Large Cell Neuroendocrine Carcinoma of the Breast, a Case Report with an Unusual Clinical Course. Breast Journal. 2015 May. 21 (3): 303-307.

Janosky M, Sabado RL, Cruz C, Vengco I, Hasan F, Winer A, Moy L, Adams S. MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy. Journal for Immunotherapy of Cancer 2014, 2:32.

Janosky M, Bian J, Dhage S, Levine J, Silverman J, Jors K, Moy L, Cangiarella J, Muggia F, Adams S. Primary Large Cell Neuroendocrine Carcinoma of the Breast, a case report with an unusual clinical course. The Breast Journal, 21(2): 2015.

Janosky M, Sabado R, Cruz C, Vengco I, Hasan F, Adams S. Ex-vivo detectable Mage-specific T cells correlate with complete remission in metastatic breast cancer patients after sequential immuno-endocrine therapy. Journal of Immunotherapy, 2012. 35(9): p. 730.

Daud A, Janosky M, Dubey S. Adjuvant Therapy in Melanoma: New Combination Cytokine, and Other Strategies. Medscape Review. 2008.

Rugo H, Carey L, Janosky M. Emerging Therapeutic Options for Patients with ER/PR/HER2-Negative Metastatic Breast Cancer. “The Oncologist”